Clinical Textbook of Addictive Disorders

Avram H Mack

ISBN 10: 146252169X / ISBN 13: 9781462521692

Editore: Guilford Publications Mai 2016, 2016

Riguardo questo articolo

Neuware - This state-of-the-science reference and text has given thousands of practitioners and students a strong foundation in understanding and treating addictive disorders. Leading experts address the neurobiology of addictions and review best practices in assessment and diagnosis. Specific substances of abuse are examined in detail, with attention to real-world clinical considerations. Issues in working with particular populations--including polysubstance abusers, culturally diverse patients, older adults, chronic pain sufferers, and others--are explored. Chapters summarize the theoretical and empirical underpinnings of widely used psychosocial and pharmacological treatments and clearly describe clinical techniques. New to This Edition \*Incorporates a decade's worth of major advances in research and clinical practice. \*Updated for DSM-5. \*Many new authors; extensively revised with the latest information on specific biological mechanisms, substances, populations, and treatments. \*Chapter on motivational interviewing.

Codice articolo 9781462521692

Dati bibliografici

• Titolo: Clinical Textbook of Addictive Disorders
• Editore: Guilford Publications Mai 2016
• Data di pubblicazione: 2016
• Lingua: Inglese
• ISBN 10: 146252169X
• ISBN 13: 9781462521692
• Rilegatura: Buch
• Edizione: quarta edizione
• Condizione: Neu
• Dimensioni: 262 L x 185 A x 46 P (millimetri) 262 millimetri di larghezza per 185 millimetri di altezza per 46 millimetri di profondità
• Peso: 1542 grammi

Descrizione articolo

Riassunto

This state-of-the-science reference and text has given thousands of practitioners and students a strong foundation in understanding and treating addictive disorders. Leading experts address the neurobiology of addictions and review best practices in assessment and diagnosis. Specific substances of abuse are examined in detail, with attention to real-world clinical considerations. Issues in working with particular populations--including polysubstance abusers, culturally diverse patients, older adults, chronic pain sufferers, and others--are explored. Chapters summarize the theoretical and empirical underpinnings of widely used psychosocial and pharmacological treatments and clearly describe clinical techniques.

New to This Edition
*Incorporates a decade's worth of major advances in research and clinical practice.
*Updated for DSM-5.
*Many new authors; extensively revised with the latest information on specific biological mechanisms, substances, populations, and treatments.
*Chapter on motivational interviewing.

Informazioni sull'autore

Avram H. Mack, MD, is Associate Chair for Quality and Safety at the Children’s Hospital of Philadelphia, where he is a practicing psychiatrist with a focus on substance use disorders and forensic, child, adult, and consultation–liaison psychiatry. Dr. Mack leads efforts on quality and patient safety and has had extensive experience as a teacher and administrator in undergraduate and graduate medical education for trainees and staff at the University of Pennsylvania, the Children’s Hospital of Philadelphia, and previously at Georgetown University. He is board-certified in general psychiatry, child and adolescent psychiatry, forensic psychiatry, and addiction medicine and presents, publishes, and testifies extensively regarding substance abuse. A past president of the Washington Psychiatric Society, he served on the board of directors of the American Psychiatric Association and on the Impaired Physicians Committee of the Medical Society of the District of Columbia. A distinguished Fellow of the American Psychiatric Association and a Fellow of the American College of Psychiatrists, Dr. Mack is a recipient of the Education Award presented by the Association for Academic Psychiatry in recognition of his efforts in advancing the patient safety movement within psychiatry.

Kathleen T. Brady, MD, PhD, is Distinguished University Professor and Director of the South Carolina Clinical and Translational Research Institute at the Medical University of South Carolina. Her interests include drug and alcohol abuse/addiction and comorbid conditions. A board-certified psychiatrist, Dr. Brady leads numerous research projects and served as president of the American Academy of Addiction Psychiatry, a member of the Scientific Advisory Council of the National Institute on Drug Abuse, and a board member of the College on Problems of Drug Dependence. She has authored over 300 publications; presented at conferences, grand rounds, and symposia; and received numerous awards.

Sheldon I. Miller, MD, until his death in 2011, was Emeritus Professor of Psychiatry and former Chairman of the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. Recognized as a national leader in addiction psychiatry, he was a cofounder of the American Academy of Addiction Psychiatry. Dr. Miller was the author of more than 100 publications and Editor-in-Chief of the American Journal on Addictions. He served on the Board of Directors of the Accreditation Council for Graduate Medical Education and the American Board of Emergency Medicine and was a Distinguished Fellow of the American Psychiatric Association and a member of the Group for the Advancement of Psychiatry.

Richard J. Frances, MD, is Clinical Professor of Psychiatry at New York University School of Medicine and Adjunct Professor at Rutgers New Jersey Medical School. He maintains a private practice in New York and was instrumental in the recognition of addiction psychiatry as a medical subspecialty. Board-certified in psychiatry and addiction psychiatry, Dr. Frances was a cofounder and first president of the American Academy of Addiction Psychiatry, Director of Education at the University of Medicine and Dentistry of New Jersey (now part of Rutgers Biomedical and Health Sciences), Chair of the Department of Psychiatry at Hackensack University Medical Center, and President and Medical Director of Silver Hill Hospital. He has also held leadership positions at New York Hospital–Cornell Medical Center and has a special interest in addiction, with a focus on impaired professionals.